Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

KAMDEM, NNEKA

NPI: 1083973036 · LOS ANGELES, CA 90003 · Hospitalist Physician · NPI assigned 05/11/2012

$0.00
Total Medicaid Paid
9,028
Total Claims
8,740
Beneficiaries
31
Codes Billed
2020-11
First Month
2024-12
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 120 $0.00
2021 1,741 $0.00
2022 1,781 $0.00
2023 2,538 $0.00
2024 2,848 $0.00

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
83036 Hemoglobin; glycosylated (A1C) 479 479 $0.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 1,109 1,093 $0.00
80053 Comprehensive metabolic panel 71 71 $0.00
1111F 96 91 $0.00
36415 Collection of venous blood by venipuncture 1,444 1,392 $0.00
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 549 507 $0.00
85025 Blood count; complete (CBC), automated, and automated differential WBC count 102 101 $0.00
4450F 240 236 $0.00
3044F 90 90 $0.00
96161 274 273 $0.00
99441 153 131 $0.00
3074F 395 372 $0.00
85027 65 65 $0.00
1220F 115 114 $0.00
90686 90 90 $0.00
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 12 12 $0.00
90472 Immunization administration, each additional vaccine (list separately) 473 468 $0.00
3078F 374 353 $0.00
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 124 105 $0.00
80061 Lipid panel 561 557 $0.00
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 858 806 $0.00
96160 157 157 $0.00
G9920 Screening performed and negative 814 812 $0.00
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 147 140 $0.00
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 12 12 $0.00
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 14 14 $0.00
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 97 87 $0.00
86703 24 24 $0.00
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 38 37 $0.00
84460 25 25 $0.00
90473 26 26 $0.00